UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues

Cancer biology & therapy, 2009-05, Vol.8 (10), p.907-916

2009

Volltextzugriff (PDF)

Multiple eccrine poromas in the setting of total body irradiation and immunosuppression

Journal of the American Academy of Dermatology, 2006-08, Vol.55 (2), p.S46-S49

2006

Volltextzugriff (PDF)

Volatile biomarkers from human melanoma cells

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013-07, Vol.931, p.90-96

2013

Volltextzugriff (PDF)

Evaluation of Reliability, Validity, and Responsiveness of the CDASI and the CAT-BM

Journal of investigative dermatology, 2012-04, Vol.132 (4), p.1117-1124

2012

Volltextzugriff (PDF)

Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria

Current drug metabolism, 2003-04, Vol.4 (2), p.151-170

2003

Volltextzugriff (PDF)

Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-α receptor

Blood, 2008-09, Vol.112 (6), p.2484-2488

2008

Volltextzugriff (PDF)

Acute Mixed-Lineage Leukemia t(4;11)(q21;q23) Generates an MLL-AF4 Fusion Product

Proceedings of the National Academy of Sciences - PNAS, 1993-08, Vol.90 (16), p.7884-7888

1993

Volltextzugriff (PDF)

Cutaneous gene therapy for haemophilia

Expert opinion on biological therapy, 2004-06, Vol.4 (6), p.763-766

Fakharzadeh, Steven S

2004

Volltextzugriff (PDF)

Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line

The EMBO journal, 1991-06, Vol.10 (6), p.1565-1569

1991

Volltextzugriff (PDF)

Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin

Blood, 2000-05, Vol.95 (9), p.2799-2805

2000

Volltextzugriff (PDF)

Clinical and in vitro resistance to bexarotene in adult T-cell leukemia : loss of RXR-a receptor

Blood, 2008, Vol.112 (6), p.2484-2488

2008

Volltextzugriff (PDF)

Correlation between Factor VIII Genotype and Inhibitor Development in Hemophilia A

Seminars in thrombosis and hemostasis, 2000, Vol.26 (2), p.167-172

2000

Volltextzugriff (PDF)

Structure and Organization of Amplified DNA on Double Minutes Containing the mdm2 Oncogene

Genomics (San Diego, Calif.), 1993-02, Vol.15 (2), p.283-290

1993

Volltextzugriff (PDF)

Livedo reticularis and inflammatory carcinoma of the breast

Journal of the American Academy of Dermatology, 1994-10, Vol.31 (4), p.689-690

1994

Volltextzugriff (PDF)

Capítulo 2 - Bases genéticas del cáncer de piel

Cáncer de Piel, p.15-27

Volltextzugriff (PDF)

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An Outcome Instrument for Cutaneous Lupus Erythematosus

Journal of investigative dermatology, 2005-11, Vol.125 (5), p.889-894

2005

Volltextzugriff (PDF)

IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy

Frontiers in immunology, 2024, Vol.15, p.1331217-1331217

2024

Volltextzugriff (PDF)

Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Journal of drugs in dermatology, 2015-07, Vol.14 (7), p.706

2015

Volltextzugriff (PDF)

Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry

Journal of the American Academy of Dermatology, 2017-11, Vol.77 (5), p.845-854.e5

2017

Volltextzugriff (PDF)

54148 Characteristics of Real-world Patients With Psoriasis Prescribed Guselkumab or Interleukin-17 Inhibitors: Data From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB152-AB152

2024

Volltextzugriff (PDF)

Effect of Diabetes on Tubular Density and Push-out Bond Strength of Mineral Trioxide Aggregate to Dentin

Journal of endodontics, 2020-11, Vol.46 (11), p.1584-1591

2020

Volltextzugriff (PDF)

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

JAMA dermatology (Chicago, Ill.), 2015-09, Vol.151 (9), p.961

2015

Volltextzugriff (PDF)

Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])

Journal of the American Academy of Dermatology, 2016-05, Vol.74 (5), p.851-861.e4

2016

Volltextzugriff (PDF)

Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis

Journal of the American Academy of Dermatology, 2021-01, Vol.84 (1), p.60-69

2021

Volltextzugriff (PDF)

Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials

Journal of the American Academy of Dermatology, 2012-05, Vol.66 (5), p.742-751

2012

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Englisch
(47)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(34)
Humans
(31)
Dermatology
(21)
Female
(16)
Adult
(14)
Male
(14)
Middle Aged
(13)
Biological And Medical Sciences
(12)
Psoriasis
(11)
Medical Sciences
(10)
Severity Of Illness Index
(10)
Psoriasis - Drug Therapy
(9)
Aged
(8)
Animals
(7)
Registries
(7)
Ustekinumab
(6)
Biological Products - Therapeutic Use
(4)
Dose-Response Relationship, Drug
(4)
Follow-Up Studies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues

Multiple eccrine poromas in the setting of total body irradiation and immunosuppression

Volatile biomarkers from human melanoma cells

Evaluation of Reliability, Validity, and Responsiveness of the CDASI and the CAT-BM

Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria

Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-α receptor

Acute Mixed-Lineage Leukemia t(4;11)(q21;q23) Generates an MLL-AF4 Fusion Product

Cutaneous gene therapy for haemophilia

Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line

Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin

Clinical and in vitro resistance to bexarotene in adult T-cell leukemia : loss of RXR-a receptor

Correlation between Factor VIII Genotype and Inhibitor Development in Hemophilia A

Structure and Organization of Amplified DNA on Double Minutes Containing the mdm2 Oncogene

Livedo reticularis and inflammatory carcinoma of the breast

Capítulo 2 - Bases genéticas del cáncer de piel

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An Outcome Instrument for Cutaneous Lupus Erythematosus

IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy

Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry

54148 Characteristics of Real-world Patients With Psoriasis Prescribed Guselkumab or Interleukin-17 Inhibitors: Data From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Effect of Diabetes on Tubular Density and Push-out Bond Strength of Mineral Trioxide Aggregate to Dentin

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])

Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis

Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials

Suchergebnisse filtern